Comparative Pharmacology
Head-to-head clinical analysis: MILTOWN versus TRANMEP.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MILTOWN versus TRANMEP.
MILTOWN vs TRANMEP
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Miltown (meprobamate) is a carbamate derivative that acts as a central nervous system depressant. Its mechanism of action is not fully understood, but it is believed to exert its effects by modulating GABAergic neurotransmission, possibly by binding to GABA receptors and enhancing inhibitory neurotransmission. It also has sedative, anxiolytic, and muscle relaxant properties.
Tianeptine is a selective serotonin reuptake enhancer (SSRE) and also modulates glutamatergic signaling via AMPA and NMDA receptors. It increases serotonin transport in presynaptic neurons and enhances neuroplasticity.
400 mg orally 3-4 times daily; maximum 2400 mg/day.
50 mg orally every 8 hours, may increase to 100 mg every 8 hours if needed.
None Documented
None Documented
10 hours (range 6-17 hours); prolonged in hepatic or renal impairment.
4-6 hours in adults; prolonged in hepatic impairment (up to 12 hours) and elderly.
Primarily renal, with 10-20% excreted unchanged; remainder as inactive metabolites (e.g., hydroxymeprobamate). Less than 2% fecal.
Renal: ~60% as unchanged drug, biliary/fecal: ~30% as metabolites, remainder as unchanged drug.
Category C
Category C
Anxiolytic
Anxiolytic